What is Glyceryl Behenate?
Glyceryl behenate (CAS Number: 77538-19-3) is a synthetic lipophilic compound formed through the esterification of glycerin with behenic acid (a long-chain saturated fatty acid with 22 carbon atoms). It appears as a white to off-white waxy solid at room temperature and is practically insoluble in water but soluble in organic solvents and oils. The compound belongs to the broader category of glycerides and synthetic fats used in food and pharmaceutical manufacturing.
Common Uses
Glyceryl behenate is primarily utilized as a formulation aid in pharmaceutical and cosmetic industries rather than as a direct food ingredient. In these applications, it functions as a binder, emollient, and processing aid that helps improve the texture, stability, and manufacturability of products. Its hydrophobic nature and high melting point make it useful in solid dosage forms, coating applications, and lipid-based delivery systems. While theoretically applicable to food formulations, its use in food products is not widespread in most regulatory jurisdictions.
Safety Assessment
The available toxicological data on glyceryl behenate is limited compared to more commonly used food additives. No adverse events have been recorded in FDA databases, and no food recalls have been associated with this ingredient. The compound's structure—being derived from naturally occurring fatty acids and glycerin—suggests a low inherent toxicity profile. However, the lack of extensive safety studies specific to food consumption and the absence of GRAS status from the FDA indicate that comprehensive safety data may not be publicly available or may be incomplete.
As a synthetic ester of a natural fatty acid, glyceryl behenate would be expected to undergo typical digestive processes similar to other dietary lipids, though human bioavailability studies appear limited. Animal studies conducted for pharmaceutical applications have generally not raised significant safety concerns, but these do not necessarily translate directly to food safety conclusions. The long-chain nature of behenic acid suggests minimal systemic absorption, with most material likely passing through the gastrointestinal tract relatively unchanged.
Regulatory Status
Glyceryl behenate has not been formally affirmed as GRAS (Generally Recognized as Safe) by the FDA for food use in the United States. It is, however, approved for use in pharmaceutical and cosmetic applications under various regulatory frameworks. In the European Union, similar fatty acid glycerides appear on permitted ingredient lists for specific food applications, though glyceryl behenate specifically may have limited authorization. Manufacturers considering its use in food products would need to comply with applicable regulations in their target markets and may need to submit additional safety data to regulatory authorities.
The lack of GRAS status does not necessarily indicate safety concerns; rather, it reflects the limited history of use in food applications and the absence of a formal safety petition or determination by the FDA.
Key Studies
Direct published research specifically addressing glyceryl behenate's safety in food consumption is sparse. Available data derives primarily from pharmaceutical toxicology literature, where oral LD50 studies in animals have suggested relatively low acute toxicity. Studies on similar long-chain fatty acid esters indicate they are poorly absorbed and pass largely through the gastrointestinal tract unchanged. Chronic toxicity studies relevant to pharmaceutical use have not identified target organs of concern at the doses evaluated, though food-specific safety assessments have not been comprehensively published in peer-reviewed scientific literature.
Research on behenic acid metabolism suggests it undergoes beta-oxidation similar to other long-chain fatty acids, with minimal bioaccumulation potential. However, direct studies on glyceryl behenate specifically in human subjects appear absent from the published scientific record.